Related Experiment Video
Updated: Jun 27, 2026
06:41
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
Prediction of disease-associated single nucleotide polymorphisms using virtual genomes constructed from a public
S Toyabe1, A Miyashita, N Kitamura
1Department of Medical Informatics, Niigata University Medical and Dental Hospital, Niigata, Japan. toyabe@med.niigata-u.ac.jp
Methods of Information in Medicine
|December 6, 2008
Summary
This study introduces a simulation-based method to reduce the number of single nucleotide polymorphisms (SNPs) for genome-wide association studies. The approach significantly decreases candidate SNPs, improving the efficiency and sensitivity of genetic association analyses.
Area of Science:
- Genetics
- Bioinformatics
- Statistical Genetics
Background:
- Genome-wide association studies (GWAS) involve analyzing hundreds of thousands of single nucleotide polymorphisms (SNPs), which is a laborious process.
- Reducing the number of SNPs before genotyping is crucial for efficient and cost-effective genetic studies.
Purpose of the Study:
- To develop a novel method for decreasing the number of candidate SNPs prior to genotyping in GWAS.
- To enhance the efficiency and sensitivity of identifying significant genetic associations.
Main Methods:
- Utilized a haplotype-based simulation method with virtual genotype data from the International HapMap Project.
- Performed virtual case-control association studies to select candidate SNPs.
- Applied the selected SNPs to previously published genetic case-control studies for validation.
Main Results:
- Identified a discrete SNP distribution pattern that yielded significant results in association studies.
- Reduced the number of candidate SNPs to 24.7% of the original set.
- Demonstrated improved sensitivity in detecting significant alleles compared to original studies and tag SNP methods, irrespective of disease or gene type.
Conclusions:
- The simulation-based approach offers significant cost reductions and performance improvements for detecting significant alleles in genetic studies.
- This method is broadly applicable across different diseases and genes, enhancing GWAS efficiency.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
02:54Evolutionary Relationships through Genome Comparisons
Genome comparison is one of the excellent ways to interpret the evolutionary relationships between organisms. The basic principle of genome comparison is that if two species share a common feature, it is likely encoded by the DNA sequence conserved between both species. The advent of genome sequencing technologies in the late 20th century enabled scientists to understand the concept of conservation of domains between species and helped them to deduce evolutionary relationships across diverse...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...